|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||34.71 / 58.95|
Here are Monday's top research calls, including downgrades for Bristol-Myers Squibb, JPMorgan and Weyerhaeuser, and an upgrade for Merck.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BLL, CCOI, CNNX, CVO, ETP, NUS, NYT, QSR, RYN, STM, STT, TRI, TSNU Downgrades: AM, CO, CPSH, EIGI, FSS, GDOT, IRM, TK, TTWO, TWO Initiations: TLN Read on to get TheStreet Quant Ratings' detailed report:
Jim Cramer says this merger of beverage can makers is a travesty that should have never been approved because it is going to cost consumers.
Ball's merger with Rexam creates the world's largest beverage can manufacturer, and creates newfound pricing power that could hurt the consumer.
Crude oil's two-day price rally continued to help lift markets.
Ball Corp. (BLL) reported 2016 second quarter earnings today, surpassing analysts’ estimates.
Both companies are posting big gains Thursday after reporting better-than-expected earnings, Cramer says.
Trade-Ideas LLC identified Ball (BLL) as a new lifetime high candidate
Ball (BLL) is slated to post second quarter earnings and revenue before tomorrow's market open.
Ball (BLL) stock coverage was reinstated with an ‘equal weight’ rating and $75 price target at Barclays on Thursday.
Trade-Ideas LLC identified Ball (BLL) as a weak on high relative volume candidate
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Ball Corp has taken over the #40 spot from CVS Health Corporation , according to ETF Channel. Below is a chart of Ball Corp versus CVS Health Corporation plotting their respective rank within the S&P 500 over time (BLL plotted in blue; CVS plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.
The most recent short interest data has been released for the 05/13/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BGSF, CLI, CLW, CRAI, DGI, EHTH, FBC, GORO, IRM, LVLT, MINI, NS, OSK, SABR, SCSS, TPX, URI Downgrades: BHE, BLL, EEI, FBRC, FGBI, FHCO, GIGM, MCS, NATI, SQBG, TZOO, UFS, USCR, XL Initiations: FNWB, RMP Read on to get TheStreet Quant Ratings' detailed report:
Mergers are getting more complex and the government is struggling to keep up. The pace of regulatory review has slowed to a crawl.
Stocks remain in the red by mid-afternoon Monday as crude oil extends its decline and drags on the energy sector.
Stocks extend their decline on Monday morning as crude oil resumes a move lower.
Stock futures extend their decline on Monday morning in a quieter start to the week ahead of a Federal Reserve announcement on Wednesday.
U.S. stock futures slide Monday while European and Asian shares slump ahead of rate-setting meetings this week of the Federal Reserve and the Bank of Japan.
A key gauge of German business confidence falls short of expectations after worries about Chinese debt push Asian indices lower.
The Colorado group agrees to sell almost double the amount of operations it was originally expecting, measured by revenue.
These heavily shorted stocks could get squeezed much higher on any positive catalyst.
Trade-Ideas LLC identified Ball (BLL) as a strong and under the radar candidate
Ball (BLL) price target was increased to $81 from $79 at Jefferies on Tuesday.
Here are Thursday's top research calls, including upgrades for Ball and FedEx, and new coverage for Adobe and Priceline.
TheStreet highlights 3 stocks pushing the consumer non-durables industry lower today.
Cramer says the market is getting it completely wrong on Bank of America and Dow Chemical.
Buy stocks with dividend protection, Cramer advises.
Jefferies increased its price target on Ball (BLL) stock to $87 from $84 on Tuesday.
Get your game plans ready because there's likely more selling ahead, Cramer warns.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.